Dolutegravir intermediate-1 minobutanoic acid) InChi: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H

InChi: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H

InChi: InChI=1S/C15H15N3O6/c16-11(14(22)23)8-17-6-5-12(19)18(15(17)24)7-9-1-3-10(4-2-9)13(20)21/h1-6

100 mg/kg) with isoproterenol groups attenuates myocyte necrosis through histopathological analysis

InChiKey: CDNAGJNJVFLMRS-BCHFMIIMSA-N

InChi: InChI=1S/C27H41NO3/c1-14-9-24-25(28-13-14)16(3)27(31-24)8-6-18-19(15(27)2)11-21-20(18)12-23(30)22-10-17(29)5-7-26(21

Dolutegravir intermediate-1 minobutanoic acid) InChi: InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10HDolutegravir intermediate 1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV) 1 infection. Product information CAS Number: 1335210 23 5 Molecular Weight: 315. 28 Formula: C13H17NO8 Chemical Name: 1 (2,2 dimethoxyethyl) 5 methoxy 6 (methoxycarbonyl) 4 oxo 1,4 dihydropyridine 3 carboxylic acid Smiles: